These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19765304)

  • 1. Determining a cost effective intervention response to HIV/AIDS in Peru.
    Aldridge RW; Iglesias D; Cáceres CF; Miranda JJ
    BMC Public Health; 2009 Sep; 9():352. PubMed ID: 19765304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.
    Creese A; Floyd K; Alban A; Guinness L
    Lancet; 2002 May; 359(9318):1635-43. PubMed ID: 12020523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.
    Bórquez A; Guanira JV; Revill P; Caballero P; Silva-Santisteban A; Kelly S; Salazar X; Bracamonte P; Minaya P; Hallett TB; Cáceres CF
    Lancet Public Health; 2019 Mar; 4(3):e127-e136. PubMed ID: 30683587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
    Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
    BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India.
    Dandona L; Kumar SG; Kumar GA; Dandona R
    BMC Health Serv Res; 2010 May; 10():117. PubMed ID: 20459755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and cost-effectiveness of the first generation of HIV prevention interventions for people with severe and persistent mental illness.
    Johnson-Masotti AP; Weinhardt LS; Pinkerton SD; Otto-Salaj LL
    J Ment Health Policy Econ; 2003 Mar; 6(1):23-35. PubMed ID: 14578545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand.
    Pattanaphesaj J; Teerawattananon Y
    BMC Public Health; 2010 Jul; 10():401. PubMed ID: 20604975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive response to the HIV/AIDS epidemic in Jamaica: a review of the past 20 years.
    Figueroa JP; Duncan J; Byfield L; Harvey K; Gebre Y; Hylton-Kong T; Hamer F; Williams E; Carrington D; Brathwaite AR
    West Indian Med J; 2008 Dec; 57(6):562-76. PubMed ID: 19580238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic.
    Sweat M; Kerrigan D; Moreno L; Rosario S; Gomez B; Jerez H; Weiss E; Barrington C
    J Health Commun; 2006; 11 Suppl 2():123-42. PubMed ID: 17148102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis.
    Silke F; Earl L; Hsu J; Janko MM; Joffe J; Memetova A; Michael D; Zheng P; Aravkin A; Murray CJL; Weaver MR
    Lancet Glob Health; 2024 Jul; 12(7):e1159-e1173. PubMed ID: 38876762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of targeted HIV prevention interventions for female sex workers in India.
    Prinja S; Bahuguna P; Rudra S; Gupta I; Kaur M; Mehendale SM; Chatterjee S; Panda S; Kumar R
    Sex Transm Infect; 2011 Jun; 87(4):354-61. PubMed ID: 21447514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.
    Gomez GB; Borquez A; Caceres CF; Segura ER; Grant RM; Garnett GP; Hallett TB
    PLoS Med; 2012; 9(10):e1001323. PubMed ID: 23055836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling up of HIV treatment for men who have sex with men in Bangkok: a modelling and costing study.
    Zhang L; Phanuphak N; Henderson K; Nonenoy S; Srikaew S; Shattock AJ; Kerr CC; Omune B; van Griensven F; Osornprasop S; Oelrichs R; Ananworanich J; Wilson DP
    Lancet HIV; 2015 May; 2(5):e200-7. PubMed ID: 26423002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base?
    Walker D
    Health Policy Plan; 2003 Mar; 18(1):4-17. PubMed ID: 12582104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating strategies to improve HIV care outcomes in Kenya: a modelling study.
    Olney JJ; Braitstein P; Eaton JW; Sang E; Nyambura M; Kimaiyo S; McRobie E; Hogan JW; Hallett TB
    Lancet HIV; 2016 Dec; 3(12):e592-e600. PubMed ID: 27771231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
    Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
    Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
    Suraratdecha C; Stuart RM; Manopaiboon C; Green D; Lertpiriyasuwat C; Wilson DP; Pavaputanon P; Visavakum P; Monkongdee P; Khawcharoenporn T; Tharee P; Kittinunvorakoon C; Martin M
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.